Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NKTX Nkarta

已收盘 10-10 16:00:00 EDT

2.16

-0.20

-8.47%

盘后2.13

-0.03-1.34%

19:54 EDT

最高2.36	最低2.12	成交量152.88万
今开2.36	昨收2.36	日振幅10.17%
总市值1.53亿	流通市值1.13亿	总股本7,102万
成交额336.72万	换手率2.91%	流通股本5,251万
市净率0.43	ROE-26.94%	每股收益-1.48
52周最高4.55	52周最低1.31	市盈率-1.46
股息0.00	股息收益率0.00	ROA-15.38%

北京优虎网络科技有限公司

{"stockData":{"symbol":"NKTX","market":"US","secType":"STK","nameCN":"Nkarta","latestPrice":2.16,"timestamp":1760126400000,"preClose":2.36,"halted":0,"volume":1528786,"hourTrading":{"tag":"盘后","latestPrice":2.1311,"preClose":2.16,"latestTime":"19:54 EDT","volume":19889,"amount":42486.2126,"timestamp":1760140445601},"delay":0,"floatShares":52510907,"shares":71024512,"eps":-1.480309,"marketStatus":"已收盘","change":-0.2,"latestTime":"10-10 16:00:00 EDT","open":2.36,"high":2.36,"low":2.1201,"amount":3367152.0822716,"amplitude":0.101653,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.480309,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1760342400000},"marketStatusCode":5,"adr":0,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":2.36,"preHourTrading":{"tag":"盘前","latestPrice":2.4,"preClose":2.36,"latestTime":"09:17 EDT","volume":3572,"amount":8575.891923199999,"timestamp":1760102276882},"postHourTrading":{"tag":"盘后","latestPrice":2.1311,"preClose":2.16,"latestTime":"19:54 EDT","volume":19889,"amount":42486.2126,"timestamp":1760140445601},"volumeRatio":0.848707,"impliedVol":0.3484,"impliedVolPercentile":0.096},"requestUrl":"/m/hq/s/NKTX","defaultTab":"news","newsList":[{"id":"2570758079","title":"Nkarta, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570758079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570758079?lang=zh_cn&edition=full","pubTime":"2025-09-26 02:02","pubTimestamp":1758823352,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日02时02分，Nkarta, Inc.股票出现异动，股价大幅下挫5.10%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为1.18%。其相关个股中，Pepgen Inc.、Scisparc Ltd.、Plus Therapeutics, Inc.涨幅较大，Scisparc Ltd.、Evaxion A/S、Qualigen Therapeutics, Inc.较为活跃，换手率分别为5218.29%、1178.22%、695.01%，振幅较大的相关个股有Scisparc Ltd.、Geovax Labs Inc C/Wts 29/09/2025、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为91.12%、70.59%、58.88%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926020233954529f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926020233954529f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2563881302","title":"Nkarta, Inc.盘中异动 股价大跌5.23%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2563881302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563881302?lang=zh_cn&edition=full","pubTime":"2025-08-30 00:58","pubTimestamp":1756486708,"startTime":"0","endTime":"0","summary":"北京时间2025年08月30日00时58分，Nkarta, Inc.股票出现波动，股价急速下挫5.23%。截至发稿，该股报2.09美元/股，成交量12.1841万股，换手率0.17%，振幅4.55%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250830005828a4a85197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250830005828a4a85197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2562704209","title":"Nkarta, Inc.盘中异动 大幅下跌5.03%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562704209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562704209?lang=zh_cn&edition=full","pubTime":"2025-08-26 02:07","pubTimestamp":1756145243,"startTime":"0","endTime":"0","summary":"北京时间2025年08月26日02时07分，Nkarta, Inc.股票出现波动，股价大幅下挫5.03%。截至发稿，该股报2.25美元/股，成交量37.6353万股，换手率0.53%，振幅5.27%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826020723a6faf3ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826020723a6faf3ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2560997970","title":"Nkarta, Inc.2025财年第二财季实现净利润-22.98百万美元，同比增加8.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560997970","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560997970?lang=zh_cn&edition=full","pubTime":"2025-08-18 00:02","pubTimestamp":1755446531,"startTime":"0","endTime":"0","summary":"8月18日，Nkarta, Inc.公布财报，公告显示公司2025财年第二财季净利润为-22.98百万美元，同比增加8.04%；其中营业收入为0.00美元，每股基本收益为-0.31美元。从资产负债表来看，Nkarta, Inc.总负债90.64百万美元，其中短期债务6.91百万美元，资产负债比为0.05，流动比率为0.16。机构评级：截至2025年8月18日，当前有5家机构对Nkarta, Inc.目标价做出预测，其中目标均价为12.40美元，其中最低目标价为8.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000506a6eb4f09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000506a6eb4f09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX"],"gpt_icon":0},{"id":"2556860817","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556860817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556860817?lang=zh_cn&edition=full","pubTime":"2025-08-01 23:01","pubTimestamp":1754060488,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日23时01分，Nkarta, Inc.股票出现异动，股价急速跳水5.07%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，天境生物、Seastar Medical Holding Corp C/Wts 28/10/2027 、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为1536.18%、175.82%、162.72%，振幅较大的相关个股有天境生物、Bioxcel Therapeutics, Inc.、Neurosense Therapeutics Ltd.，振幅分别为58.71%、42.75%、36.34%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080123012894c92fb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080123012894c92fb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2555283128","title":"Nkarta, Inc.盘中异动 早盘快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555283128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555283128?lang=zh_cn&edition=full","pubTime":"2025-07-31 22:41","pubTimestamp":1753972889,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日22时41分，Nkarta, Inc.股票出现波动，股价快速拉升5.05%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为2.97%。其相关个股中，Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Soligenix, Inc.、Onconetix, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为4746.63%、4493.72%、4491.12%，振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为103.20%、97.88%、97.44%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731224129972a7327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731224129972a7327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2555691063","title":"Nkarta, Inc.盘中异动 临近午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555691063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555691063?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:49","pubTimestamp":1753804198,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时49分，Nkarta, Inc.股票出现异动，股价急速下跌5.00%。截至发稿，该股报2.09美元/股，成交量14.9563万股，换手率0.21%，振幅5.00%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729234959a469f3b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729234959a469f3b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2552438361","title":"Nkarta, Inc.盘中异动 急速拉升5.19%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552438361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552438361?lang=zh_cn&edition=full","pubTime":"2025-07-17 23:34","pubTimestamp":1752766482,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日23时34分，Nkarta, Inc.股票出现波动，股价快速拉升5.19%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Imunon, Inc.较为活跃，换手率分别为912.35%、480.49%、216.92%，振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Clearside Biomedical, Inc.，振幅分别为148.12%、81.11%、61.99%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717233442a451738b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717233442a451738b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2551795195","title":"Nkarta, Inc.盘中异动 快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551795195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551795195?lang=zh_cn&edition=full","pubTime":"2025-07-15 23:34","pubTimestamp":1752593685,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日23时34分，Nkarta, Inc.股票出现异动，股价大幅下挫5.03%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Polyrizon Ltd.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1852.73%、1700.31%、1523.03%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为416.92%、109.47%、75.50%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152334459543a629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507152334459543a629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2549741526","title":"Nkarta, Inc.盘中异动 早盘急速上涨5.02%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549741526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549741526?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:32","pubTimestamp":1751985174,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时32分，Nkarta, Inc.股票出现异动，股价大幅拉升5.02%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。其相关个股中，Moleculin Biotech, Inc.、Rallybio Corporation、Humacyte, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为880.29%、439.15%、264.08%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Moleculin Biotech, Inc.、Rallybio Corporation，振幅分别为70.96%、69.44%、59.87%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223254953af3cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223254953af3cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2548883752","title":"Nkarta, Inc.盘中异动 股价大涨5.42%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883752?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:47","pubTimestamp":1751384827,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时47分，Nkarta, Inc.股票出现异动，股价快速上涨5.42%。截至发稿，该股报1.75美元/股，成交量13.1428万股，换手率0.19%，振幅6.63%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070123470797961530&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070123470797961530&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2542451030","title":"Nkarta, Inc.盘中异动 早盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542451030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542451030?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:51","pubTimestamp":1749736264,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时51分，Nkarta, Inc.股票出现波动，股价快速下挫5.00%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Immunoprecise Antibodies Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Klotho Neurosciences, Inc.涨幅较大，Nucana Plc、Klotho Neurosciences, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为1454.86%、93.41%、61.02%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Entero Therapeutics Inc.，振幅分别为66.62%、31.62%、24.98%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612215104a4a54e7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612215104a4a54e7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2542480823","title":"Nkarta, Inc.盘中异动 急速上涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542480823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542480823?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:07","pubTimestamp":1749564462,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时07分，Nkarta, Inc.股票出现异动，股价急速上涨5.35%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为16143.70%、2055.35%、1055.83%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Nucana Plc，振幅分别为253.85%、191.40%、99.74%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610220743a7024298&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610220743a7024298&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2541862441","title":"Nkarta, Inc.盘中异动 下午盘股价大涨5.19%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541862441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541862441?lang=zh_cn&edition=full","pubTime":"2025-06-07 01:35","pubTimestamp":1749231340,"startTime":"0","endTime":"0","summary":"北京时间2025年06月07日01时35分，Nkarta, Inc.股票出现波动，股价大幅上涨5.19%。截至发稿，该股报1.93美元/股，成交量31.2843万股，换手率0.44%，振幅6.01%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506070135409774a1f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506070135409774a1f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2541809689","title":"Nkarta, Inc.盘中异动 临近收盘大幅拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541809689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541809689?lang=zh_cn&edition=full","pubTime":"2025-06-05 03:37","pubTimestamp":1749065854,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日03时37分，Nkarta, Inc.股票出现异动，股价急速拉升5.08%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Cellectar Biosciences, Inc.、Hoth Therapeutics, Inc.、Lyell Immunopharma, Inc.涨幅较大，Nucana Plc、Cellectar Biosciences, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1716.92%、1326.42%、623.00%，振幅较大的相关个股有Cellectar Biosciences, Inc.、Hoth Therapeutics, Inc.、Liminatus Pharma, Inc.，振幅分别为106.81%、82.62%、69.81%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506050337349771e361&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506050337349771e361&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2539715902","title":"Nkarta, Inc.盘中异动 股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539715902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539715902?lang=zh_cn&edition=full","pubTime":"2025-05-31 00:30","pubTimestamp":1748622644,"startTime":"0","endTime":"0","summary":"北京时间2025年05月31日00时30分，Nkarta, Inc.股票出现异动，股价急速下挫5.25%。截至发稿，该股报1.72美元/股，成交量9.5135万股，换手率0.13%，振幅5.25%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为4.16%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531003044a49319db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531003044a49319db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2537923222","title":"Nkarta, Inc.2025财年第一财季实现净利润-31.98百万美元，同比减少8.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537923222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537923222?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929636,"startTime":"0","endTime":"0","summary":"5月23日，Nkarta, Inc.公布财报，公告显示公司2025财年第一财季净利润为-31.98百万美元，同比减少8.33%；其中营业收入为0.00美元，每股基本收益为-0.43美元。从资产负债表来看，Nkarta, Inc.总负债91.80百万美元，其中短期债务5.95百万美元，资产负债比为0.06，流动比率为0.15。机构评级：截至2025年5月23日，当前有5家机构对Nkarta, Inc.目标价做出预测，其中目标均价为13.20美元，其中最低目标价为8.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000140a48876a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000140a48876a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX"],"gpt_icon":0},{"id":"2537955264","title":"Nkarta, Inc.盘中异动 下午盘大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537955264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537955264?lang=zh_cn&edition=full","pubTime":"2025-05-22 02:56","pubTimestamp":1747853809,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日02时56分，Nkarta, Inc.股票出现波动，股价快速下挫5.06%。截至发稿，该股报1.71美元/股，成交量14.1488万股，换手率0.20%，振幅5.00%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052202565097611261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052202565097611261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2537644483","title":"Nkarta, Inc.盘中异动 股价大涨5.00%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537644483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537644483?lang=zh_cn&edition=full","pubTime":"2025-05-21 00:22","pubTimestamp":1747758157,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日00时22分，Nkarta, Inc.股票出现波动，股价大幅上涨5.00%。截至发稿，该股报1.79美元/股，成交量18.0093万股，换手率0.25%，振幅5.29%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521002238a6e64938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521002238a6e64938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2535682609","title":"Nkarta, Inc.盘中异动 早盘大幅下跌6.95%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535682609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535682609?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:30","pubTimestamp":1747315849,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时30分，Nkarta, Inc.股票出现波动，股价快速下跌6.95%。截至发稿，该股报1.74美元/股，成交量7.3485万股，换手率0.10%，振幅0.00%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Nkarta, Inc.公司简介：Nkarta Inc 是一家临床阶段的生物制药公司，率先开发同种异体、现成的工程自然杀伤  细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213049975abe8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213049975abe8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4139","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nkartatx.com","stockEarnings":[{"period":"1week","weight":0.0776},{"period":"1month","weight":0.1401},{"period":"3month","weight":0.2896},{"period":"6month","weight":0.4984},{"period":"1year","weight":-0.401},{"period":"ytd","weight":-0.0522}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.032},{"period":"3month","weight":0.0762},{"period":"6month","weight":0.257},{"period":"1year","weight":0.1629},{"period":"ytd","weight":0.1452}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nkarta, Inc.于2015年7月在特拉华州成立。该公司一家临床阶段的生物制药公司，致力于开发同种异体、现成的工程自然杀伤（“NK”）细胞疗法，用于治疗自身免疫性疾病或血液恶性肿瘤患者。该公司成立的信念是，工程NK细胞疗法可以通过提供具有临床意义、广泛可及且不受其他细胞治疗方法相关的安全问题影响的疗法来改变患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.101986},{"month":2,"riseRate":0.4,"avgChangeRate":0.003163},{"month":3,"riseRate":0.4,"avgChangeRate":-0.055532},{"month":4,"riseRate":0.6,"avgChangeRate":0.150592},{"month":5,"riseRate":0.2,"avgChangeRate":-0.136477},{"month":6,"riseRate":0.2,"avgChangeRate":-0.109268},{"month":7,"riseRate":1,"avgChangeRate":0.107935},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.06764},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.061634},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.040155},{"month":11,"riseRate":0.6,"avgChangeRate":0.015473},{"month":12,"riseRate":0.4,"avgChangeRate":0.377407}],"exchange":"NASDAQ","name":"Nkarta","nameEN":"Nkarta"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nkarta,NKTX,Nkarta股票,Nkarta股票老虎,Nkarta股票老虎国际,Nkarta行情,Nkarta股票行情,Nkarta股价,Nkarta股市,Nkarta股票价格,Nkarta股票交易,Nkarta股票购买,Nkarta股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}